Max Robotics — Global Service Robot Directory + US Certification

About

Mika Hukkanen’s research centers on the vascular pathology underlying systemic sclerosis (SSc) and inflammatory myopathies, with a particular focus on the failure of angiogenesis in these diseases. His most cited work, “Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin” (67 citations), demonstrated that despite elevated vascular endothelial growth factor (VEGF), the disrupted receptor balance prevents effective new blood vessel formation, contributing to tissue damage. This finding was reinforced by his study “Vascular damage and lack of angiogenesis in systemic sclerosis skin” (42 citations), which established a paradigm of impaired vascular repair in SSc. Hukkanen also explored similar mechanisms in inflammatory myopathies, showing in “Disease-associated increased HIF-1, αvβ3 integrin, and Flt-1 do not suffice to compensate the damage-inducing loss of blood vessels” (24 citations) that hypoxia-inducible factors and integrins fail to rescue muscle vasculature. His work on caspase-1 and cytokine signaling in myopathies (25 citations) further elucidated dual roles in degeneration and regeneration. Collectively, Hukkanen’s contributions have shaped our understanding of how failed angiogenesis drives fibrosis and muscle damage, offering critical insights for therapeutic strategies aimed at restoring vascular homeostasis.